Cachexia - Induced cerebellar degeneration: Involvement of serum TNF and MCP-1 in the course of experimental neoplastic disease

Acta Neurobiologiae Experimentalis

Volumn 66, Issue 2, 2006, Pages 113-122

  Michalak, Sławomir ^a,b   Wender, Mieczysław ^b   Michałowska Wender, Grazyna ^a,b  

^a POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

^b MOSSAKOWSKI MEDICAL RESEARCH CENTRE   (Poland)

Author keywords

Cachexia; Monocyte chemoattractant protein 1; Neurological paraneoplastic syndrome; Paraneoplastic cerebellar degeneration; Tumor necrosis factor

Indexed keywords

EOSIN; HEMATOXYLIN; INSULIN; MONOCYTE CHEMOTACTIC PROTEIN 1; THYROXINE; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CACHEXIA; CELL DENSITY; CEREBELLUM ATROPHY; CEREBELLUM DEGENERATION; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; MALE; MICROSCOPY; MORRIS HEPATOMA; NEOPLASM; NISSL STAINING; NONHUMAN; PURKINJE CELL; RADIOIMMUNOASSAY; RAT; TUMOR GROWTH;

ANIMALS; ATROPHY; CACHEXIA; CHEMOKINE CCL2; INSULIN; LIVER NEOPLASMS; LIVER NEOPLASMS, EXPERIMENTAL; MALE; NEOPLASM TRANSPLANTATION; PARANEOPLASTIC CEREBELLAR DEGENERATION; PURKINJE CELLS; RATS; RATS, INBRED BUF; THYROXINE; TUMOR NECROSIS FACTOR-ALPHA;

EID: 33746443796     PISSN: 00651400     EISSN: 00651400     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Abercrombie M (1946) Estimation of nuclear population from microtome sections. Anat Rec 94: 239-247.
2. Alvarez M, Perez-Castillo A, Santos A (2005) Thyroid hormone regulates Gai1 gene expression in the rat cerebellar cortex during post-natal development. J Neurochem 92: 395-404.
3. Bernal F, Shams'ili S, Rojas I, Sanchez-Valle R, Saiz A, Dalmau J, Honnorat J, Smitt PS, Grauss F (2003) Anti-Tr antibodies as markers of paraneoplastic cerebellar degeneration and Hodgkin's disease. Neurology 60: 230-234.
4. Bozcuk H, Uslu G, Samur M, Yildiz M, Ozben T, Ozdogan M, Artac M, Altunbas H, Akan I, Savas B (2004) Tumour necrosis factor-alpha, interleukin-6, and fasting serum insulin correlate with clinical outcome in metastatic breast cancer patients treated with chemotherapy. Cytokine 27: 58-65.
5. Brain L, Wilkinson M (1965) Subacute cerebellar degeneration associated with neoplasms. Brain 88: 465-478.
6. Catalano MG, Fortunati N, Arena K, Costelli P, Aragno M, Danni O, Boccuzzi G (2003) Selective up-regulation of tumor necrosis factor receptor I in tumor-bearing rats with cancer-related cachexia. Int J Oncol 23: 429-436.
7. Colell A, Morales A, Fernandez-Checa JC, Garcia-Ruiz C (2002) Ceramide generated by acidic sphingomyelinase contributes to tumor necrosis factor-K-mediated apoptosis in human colon HT-29 cells through glycosphingolipids formation. Possible role of ganglioside GD3. FEBS Lett 526: 135-141.
8. Elenkov IJ, Wilder RL, Chrousos GP, ViziI ES (2000) The sympathetic nerve - an integrative interface between two supersystems: The brain and the immune system. Pharmacol Rev 52: 595-638.
9. Grauss F, Lang B, Pozo-Rosich P, Saiz A, Casamitjana R, Vincent A (2002) P/Q type calcium channel antibodies in paraneoplastic cerebellar degeneration with lung cancer. Neurology 59: 764-766.
10. Hamabe W, Fujita R, Ueda H (2003) Neuronal necrosis inhibition by insulin through protein kinase C activation. J Pharm Exp Ther 307: 205-212.
11. Heimdal JH, Aarstad HJ, Klementsen B, Olofsson J (1999) Ex vivo interleukin (IL)-1b, IL-6, IL-12 and tumor necrosis factor-a responsivness with monocytes from patients with head and neck carcinoma. Eur Arch Otorhinolaryngol 256: 250-256.
12. Heuer H, Mason CA (2003) Thyroid hormone induces cerebellar Purkinje cell dendritic development via the thyroid hormone receptor a1. J Neurosci 23: 10604-10612.
13. Holden RJ, Pakula IS, Mooney PA (1999) Tumor necrosis factor-a: A continuum of liability between insulin-dependent diabetes mellitus, non-insulindependent diabetes mellitus and carcinoma. Med Hypotheses 52: 319-323.
14. Huck S (1983) Serum-free medium for cultures of the postnatal mouse cerebellum: Only insulin is essential. Brain Res Bull 10: 667-674.
15. Kalehua AN, Nagel JE, Whelchel LM, Gides JJ, Pyle RS, Smith RJ, Kusiak JW, Taub DD (2004) Monocyte chemoattractant protein-1 and macrophage inflammatory protein-2 are involved in both excitotoxin-induced neurodegeneration and regeneration. Exp Cell Res 297: 197-211.
16. Kuratsu J, Yoshizato K, Yoshimura T, Leonard EJ, Takeshima H, Ushio Y (1993) Quantitative study of monocyte chemoattractant protein-1 (MCP-1) in cerebrospinal fluid and cyst fluid from patients with malignant glioma. J Natl Cancer Inst 85: 1836-1839.
17. Lebrecht A, Grimm C, Lantzsch T, Ludwig E, Hefler L, Ulbrich E, Koelbl H (2004)Monocyte chemoattractant protein-1 serum levels in patients with breast cancer. Tumour Biol 25: 14-17.
18. Licinio J, Wong ML (1997) Perspectives series: Cytokines and the brain. J Clin Invest 100: 2941-2947.
19. Mantovani G, Macci A, Madeddu C, Mura L, Massa E, Mudu MC, Mulas C, Lusso MR, Gramignano G, Bonaria Piras M (2001) Serum values of proinflammatory cytokines are inversely correlated with serum leptin levels in patients with advanced stage cancer at different sites. J Mol Med 79: 406-414.
20. Mehta VK, Hao W, Brooks-Worrell BM, Palmer JP (1994) Low-dose interleukin 1 and tumor necrosis factor individually stimulate insulin release but in combination cause suppression. Eur J Endocrinol 130: 208-214.
21. Meng SZ, Oka A, Takashima S (1999) Developmental expression of monocyte chemoattractant protein-1 in the human cerebellum and brainstem. Brain Dev 21: 30-35.
22. Michalaki V, Syrigos K, Charles P, Waxman J (2004) Serum levels of IL-6 and TNF-alpha correlate with clinicopathological features and patient survival in patients with prostate cancer. Br J Cancer 90: 2312-2316.
23. Morte B, Manzano J, Scanlan T, Vennstrom B, Bernal J (2002) Deletion of the thyroid hormone receptor a1 prevents the structural alterations of the cerebellum induced by hypothyroidism. Proc Natl Acad Sci U S A 99: 3985-3989.
24. Nicholson JL, Altman J (1972) Synaptogenesis in the rat cerebellum: Effects of early hypo- and hyperthyroidism. Science 176: 530-532.
25. Neveu I, Arenas E (1996) Neurotrophins promote the survival and development of neurons in the cerebellum of hypothyroid rats in vivo. J Cell Biol 133: 631-646.
26. Peterson K, Rosenblum MK, Kotanides H, Posner JB (1992) Paraneoplastic cerebellar degeneration.I. A clinical analysis of 55 anti-Yo antibody-positive patients. Neurology 42: 1931-1937.
27. Salcedo R, Ponce ML, Young HA, Wasserman K, Ward JM, Kleinman HK, Oppenheim JJ, Murphy WJ (2000) Human endothelial cells express CCR2 and respond to MCP-1: Direct role of MCP-1 in angiogenesis and tumor progression. Blood 96: 34-40.
28. Sartipy P, Loskutoff DJ (2003) Monocyte chemoattractant protein 1 in obesity and insulin resistance. Proc Natl Acad Sci U S A 100: 7265-7270.
29. Schwartz H (1983) Effect of thyroid hormone in growth and development. In: Molecular Basis of Thyroid Hormone Action (Oppenheimer J, Samuels H, eds). Academic Press, New York, p. 413-444.
30. Smitt PS, Kinoshita A, De Leeuw B, Moll W, Coesmans M, Jaarsma D, Henzen-Longmans S, Vecht Ch, De Zeeuw Ch, Sekiyama N, Nakanishi S, Shigemoto R (2003) Paraneoplastic cerebellar ataxia due to autoantibodies against a glutamate receptor. N Engl J Med 342: 21-27.
31. Stamatovic SM, Shakui P, Keep RF, More BB, Kunkel SL, Van Rooijen N. Andjelkovic AV (2005) Monocyte chemoattractant protein-1 regulation of blood-brain barrier permeability.J Cereb Blood Flow Metab 25: 593-606.
32. Sweep CG, van der Meer MJ, Ross HA, Vranck R, Visser TJ, Hermus AR (1992) Chronic infusion of TNF-alpha reduces plasma T4 binding without affecting pituitary-thyroid activity in rats. Am J Physiol 263: E1099-105.
33. Tonouchi H, Miki C, Tanaka K, Kusunoki M (2002) Profile of monocyte chemoattractant protein-1 circulating levels in gastric cancer patients. Scand J Gastroenterol 37: 830-833.
34. Venters HD, Tang Q, Liu Q, VanHoy RW, Dantzer R, Kelley KW (1999) A new mechanism of neurodegeneration: A proinflammatory cytokine inhibits receptor signaling by a survival peptide. Proc Natl Acad Sci U S A 96: 9879-9884.
35. Vick N, Schulman S, Dau P (1969) Carcinomatous cerebellar degeneration: Encephalomyelitis and sensory neuropathy (radiculitis). Neurology 19: 425-441.
36. Wilkinson PC, Żeromski J (1965) Immunofluorescent detection of antibodies against neurones in sensory carcinomatous neuropathy. Brain 88: 529-583.